Dihydropteridione derivatives, process for their manufacture and their use as medicament
Disclosed are new dihydropteridinones of the formula (I) wherein the groups L, R 1 , R 2 , R 3 , R 4 and R 5 have the meanings provided herein, the isomers thereof, processes for preparing these dihydropteridinones and their use as pharmaceutical compositions.
1. A compound of the formula (A8)
wherein
R 1 and R 2 , which may be identical or different, denote hydrogen, or a group selected from among C 1 -C 6 -alkyl, C 2 -C 6 -alkenyl and C 2 -C 6 -alkynyl, which may optionally be mono- or polysubstituted by one or more groups R 9 , or
R 1 and R 2 together denote C 2 -C 6 -alkylene, in which optionally one or two methylene groups may be replaced by one of the groups —O or —NR 7 , and which may optionally be mono- or polysubstituted by one or more groups R 9 ;
R 3 denotes hydrogen or a group selected from C 1 -C 8 -alkyl, C 2 -C 8 -alkenyl, C 2 -C 8 -alkynyl, C 3 -C 8 -cycloalkyl and C 6 -C 14 -aryl, which may optionally be mono- or polysubstituted by one or more groups R 9 ; or
R 3 and R 2 or R 3 and R 1 together denote C 2 -C 6 -alkylene which may optionally be mono- or polysubstituted by one or more groups R 9 ;
R 4 denotes hydrogen, halogen, CN, OH, —NR 7 R 8 or a group selected from among C 1 -C 6 -alkyl, C 1 -C 6 -alkyloxy, C 2 -C 6 -alkenyl, C 2 -C 6 -alkenyloxy, C 2 -C 6 -alkynyl and C 2 -C 6 -alkynyloxy, which may optionally be mono- or polysubstituted by one or more groups R 10 ;
R 7 and R 8 , which may be identical or different, denote hydrogen or C 1 -C 6 -alkyl,
R 9 denotes halogen, CN, OH or CF 3 ;
R 10 denotes halogen, OH, CN, ═O, C 1 -C 6 -alkyloxy, COOR 7 , NR 7 R 8 , CONR 7 R 8 , SO 2 R 7 , CHF 2 or CF 3 ;
optionally in the form of the tautomers, racemates, enantiomers, diastereomers and mixtures thereof, and optionally in the form of the acid addition salts thereof.